Reinforcement-enhancing effects of nicotine
尼古丁的强化作用
基本信息
- 批准号:8087136
- 负责人:
- 金额:$ 18.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-15 至 2013-04-30
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAcuteAnhedoniaAnimal ExperimentationAnimal ModelAnimalsChronicCigaretteComputersDependenceDevelopmentEnvironmentFailureFamiliarityFutureHumanIntakeLeadLinkMental DepressionMusicNicotineNicotine DependenceNoisePharmaceutical PreparationsProceduresPsychological reinforcementRelapseResearchResearch Project GrantsRewardsRodentSelf-AdministeredSex CharacteristicsSmokerSmokingSmoking BehaviorStimulusSumUnited States National Institutes of HealthWithdrawalWithholding TreatmentWomanWorkcigarette smokingdesignimprovedmenpreventprogramsreinforcersmoking cessationsuccess
项目摘要
DESCRIPTION (provided by applicant): "Reinforcement-enhancing effects of nicotine" Nicotine clearly has primary and secondary reinforcing effects in humans and animal models. Very recent research in rodents indicates that nicotine may also have a third reinforcing function; that of reinforcement-enhancing effects, or increasing the reinforcing efficacy of rewards unrelated to nicotine intake. This R21 application seeks to determine whether nicotine via smoking has reinforcement enhancing effects in humans. One hundred smokers, 50 nicotine dependent and 50 nondependent, will participate in 4 experimental sessions, involving: 1) smoking nicotine (0.6 mg) cigarettes or 2) smoking denic (0.05 mg) cigarettes or 3) no smoking, each after overnight abstinence, or 4) smoking their own brand after no overnight abstinence (exploratory condition). In each session, they will respond on a simple operant task for small amounts of money, brief access to preferred music, avoidance of aversive white noise, or no reward (control). Our primary specific aim is to examine the influence of nicotine via smoking on responding for rewards. We hypothesize that reinforced responding will be greater after smoking a nicotine vs a denic cigarette (and vs. no smoking), indicating reinforcement enhancing effects of nicotine per se. Effects of nicotine on responding for some rewards versus others or no reward will indicate that reinforcement enhancement due to nicotine is specific to certain rewards and not a generalized effect of nicotine intake. Reinforcement-enhancing effects of nicotine in nondependent smokers, as well as dependent smokers, would suggest that these effects do not require the establishment of dependence and reflect absolute enhancement of reinforcement, as observed in the rodent studies. Substantial pilot work supports project feasibility and points to the likelihood of these hypothesized results. By contrast, if effects are observed only in dependent and not nondependent smokers, they could reflect withdrawal relief and not true enhancement of reinforcement. A secondary aim is to explore sex differences in the reinforcement enhancing effects of nicotine. This research is highly significant because demonstrating reinforcement-enhancing effects of nicotine in humans would have very important implications for our understanding of nicotine dependence. It would indicate that smoking does not "just" provide reinforcement from direct psychoactive effects of nicotine but rather broadly increases the reinforcing effects of the other rewards in a smoker's environment. Therefore, quitting smoking would result in a loss of this broad reinforcement, in addition to loss of nicotine's psychoactive effects. This broad reinforcement loss could be restored by smoking one cigarette (i.e. a lapse), helping to explain the persistence of smoking behavior. Results would provide directions for improving cessation treatments. This R21 submission fits the requirements of PA-10-069, "NIH Exploratory Developmental Research Grant Program."
PUBLIC HEALTH RELEVANCE: "Reinforcement enhancing effects of nicotine" This project will determine whether nicotine via cigarette smoking increases the reinforcing value of other rewards unrelated to smoking, as indicated by recent rodent studies. Dependent and nondependent smokers will work on a computer task to earn various small rewards after smoking nicotine or denic cigarettes or not smoking. This research is highly significant because demonstrating reinforcement-enhancing effects of nicotine in humans would have very important implications for our understanding of nicotine dependence. It would indicate that smoking does not "just" provide reinforcement from direct psychoactive effects of nicotine, but rather broadly increases the reinforcing effects of the other rewards in a smoker's environment. Therefore, quitting smoking could result in a loss of this broad reinforcement, in addition to loss of nicotine's psychoactive effects. This broad reinforcement loss could be restored by smoking a cigarette (i.e. a lapse), helping to explain why a lapse almost invariably leads to relapse after a quit attempt.
描述(由申请人提供):“尼古丁的强化增强作用” 尼古丁在人类和动物模型中明显具有初级和次级强化作用。最近对啮齿动物的研究表明,尼古丁还可能具有第三种增强功能。强化增强效应,或增加与尼古丁摄入无关的奖励的强化功效。该 R21 应用旨在确定吸烟产生的尼古丁是否对人类具有强化作用。一百名吸烟者,其中 50 名尼古丁依赖者和 50 名非尼古丁依赖者,将参加 4 次实验,其中包括:1) 吸尼古丁 (0.6 毫克) 香烟或 2) 吸丹尼古丁 (0.05 毫克) 香烟或 3) 不吸烟,每次都在隔夜戒烟后,或4)在没有隔夜戒烟后吸烟自己的品牌(探索性条件)。在每次训练中,他们都会对一个简单的操作任务做出反应,只需花费少量的钱,短暂地访问喜欢的音乐,避免令人厌恶的白噪音,或者没有奖励(控制)。我们的主要具体目标是研究吸烟产生的尼古丁对奖励反应的影响。我们假设,与吸普通香烟(以及与不吸烟)相比,吸尼古丁后的强化反应会更大,这表明尼古丁本身的强化增强作用。尼古丁对某些奖励与其他奖励或无奖励的反应的影响表明,尼古丁引起的强化增强是特定于某些奖励的,而不是尼古丁摄入的普遍影响。尼古丁对非依赖吸烟者和依赖吸烟者的强化增强作用表明,这些作用不需要建立依赖性,并且反映了强化的绝对增强,正如在啮齿动物研究中观察到的那样。大量的试点工作支持了项目的可行性,并指出了这些假设结果的可能性。相比之下,如果仅在依赖吸烟者而非非依赖吸烟者中观察到效果,则它们可能反映了戒断缓解,而不是真正的强化增强。第二个目标是探索尼古丁强化效果的性别差异。这项研究非常重要,因为证明尼古丁对人类的增强作用将对我们理解尼古丁依赖产生非常重要的影响。这表明吸烟不仅“仅仅”增强了尼古丁的直接精神活性作用,而且广泛地增强了吸烟者环境中其他奖励的增强作用。因此,戒烟除了失去尼古丁的精神作用外,还会导致这种广泛的强化作用的丧失。这种广泛的强化损失可以通过吸一支烟(即戒烟)来恢复,这有助于解释吸烟行为的持续性。结果将为改进戒烟治疗提供方向。此 R21 提交符合 PA-10-069“NIH 探索性发展研究资助计划”的要求。
公共健康相关性:“尼古丁的强化作用” 该项目将确定通过吸烟产生的尼古丁是否会增加与吸烟无关的其他奖励的强化价值,正如最近的啮齿动物研究所表明的那样。依赖和非依赖吸烟者在吸尼古丁或丹尼香烟或不吸烟后,将完成计算机任务以获得各种小奖励。这项研究非常重要,因为证明尼古丁对人类的增强作用将对我们理解尼古丁依赖产生非常重要的影响。这表明吸烟不仅“仅仅”增强了尼古丁的直接精神活性作用,而且广泛地增强了吸烟者环境中其他奖励的增强作用。因此,戒烟除了失去尼古丁的精神作用外,还可能导致这种广泛的强化作用的丧失。这种广泛的强化损失可以通过吸烟(即戒烟)来恢复,这有助于解释为什么在尝试戒烟后,戒烟几乎总是会导致复发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH Alan PERKINS其他文献
KENNETH Alan PERKINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH Alan PERKINS', 18)}}的其他基金
First-in-Human Clinical Development of a Novel Drug Candidate with a First-in-Class Mechanism for Smoking Cessation and Abstinence
具有一流戒烟和节欲机制的新候选药物的首次人体临床开发
- 批准号:
10452567 - 财政年份:2021
- 资助金额:
$ 18.94万 - 项目类别:
First-in-Human Clinical Development of a Novel Drug Candidate with a First-in-Class Mechanism for Smoking Cessation and Abstinence
具有一流戒烟和节欲机制的新候选药物的首次人体临床开发
- 批准号:
10620310 - 财政年份:2021
- 资助金额:
$ 18.94万 - 项目类别:
First-in-Human Clinical Development of a Novel Drug Candidate with a First-in-Class Mechanism for Smoking Cessation and Abstinence
具有一流戒烟和节欲机制的新候选药物的首次人体临床开发
- 批准号:
10328576 - 财政年份:2021
- 资助金额:
$ 18.94万 - 项目类别:
Threshold Dose for Nicotine Discrimination in Cigarettes
香烟中尼古丁歧视的阈剂量
- 批准号:
8573038 - 财政年份:2013
- 资助金额:
$ 18.94万 - 项目类别:
Threshold Dose for Nicotine Discrimination in Cigarettes
香烟中尼古丁歧视的阈剂量
- 批准号:
8720746 - 财政年份:2013
- 资助金额:
$ 18.94万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Neurobiological impact of acute digital media abstinence among drug using college students
吸毒大学生急性数字媒体戒断的神经生物学影响
- 批准号:
10677380 - 财政年份:2023
- 资助金额:
$ 18.94万 - 项目类别:
Biochemical Studies Underlying Acute Ethanol's Antidepressant-like effects during Withdrawal in a Preclinical Model of Ethanol Dependence
乙醇依赖临床前模型中戒断期间乙醇急性抗抑郁样作用的生化研究
- 批准号:
10595193 - 财政年份:2023
- 资助金额:
$ 18.94万 - 项目类别:
A controlled evaluation of abstinence-induced withdrawal and motivation to vape/smoke among daily ENDS users vs. cigarette smokers
对日常 ENDS 使用者与吸烟者的戒断引起的戒断和吸电子烟/吸烟动机的对照评估
- 批准号:
10633148 - 财政年份:2022
- 资助金额:
$ 18.94万 - 项目类别:
A controlled evaluation of abstinence-induced withdrawal and motivation to vape/smoke among daily ENDS users vs. cigarette smokers
对日常 ENDS 使用者与吸烟者的戒断引起的戒断和吸电子烟/吸烟动机的对照评估
- 批准号:
10428192 - 财政年份:2022
- 资助金额:
$ 18.94万 - 项目类别:
Dissecting the contribution of glutamatergic ventral pallidal neurons to the aversive state of opioid withdrawal
剖析谷氨酸能腹侧苍白球神经元对阿片类药物戒断厌恶状态的贡献
- 批准号:
10464731 - 财政年份:2022
- 资助金额:
$ 18.94万 - 项目类别: